FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Gilead Settles Five Lawsuits With Generic Drugmakers Over Descovy, Odefsey and Vemlidy September 13, 2022 House E&C Committee Leaders Seek Additional Info on FDA’s Heparin Investigations March 15, 2017 White House Tells FDA and Other Agencies to Prepare for Staff Cuts as Hiring Freeze Ends April 12, 2017
Gilead Settles Five Lawsuits With Generic Drugmakers Over Descovy, Odefsey and Vemlidy September 13, 2022
White House Tells FDA and Other Agencies to Prepare for Staff Cuts as Hiring Freeze Ends April 12, 2017